These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6095483)

  • 41. The effects of siguazodan, a selective phosphodiesterase inhibitor, on human platelet function.
    Murray KJ; England PJ; Hallam TJ; Maguire J; Moores K; Reeves ML; Simpson AW; Rink TJ
    Br J Pharmacol; 1990 Mar; 99(3):612-6. PubMed ID: 2158847
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Morphine-potentiated agonist-induced platelet aggregation through alpha2-adrenoceptors in human platelets.
    Sheu JR; Yeh GC; Fang CL; Lin CH; Hsiao G
    J Cardiovasc Pharmacol; 2002 Nov; 40(5):743-50. PubMed ID: 12409983
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High concentrations of exogenous arachidonate inhibit calcium mobilization in platelets by stimulation of adenylate cyclase.
    Kowalska MA; Rao AK; Disa J
    Biochem J; 1988 Jul; 253(1):255-62. PubMed ID: 2458717
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased platelet aggregation due to chilling to 20 degrees C is not related to increased sensitivity to agonists.
    Hansen TN; Brockbank KG
    Transfusion; 1997 Jul; 37(7):696-702. PubMed ID: 9225932
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cell response kinetics: the phenomenon of supercooperativity in aggregation of human platelets.
    Vrzheshch PV; Tatarintsev AV; Yershov DE; Varfolomeyev SD
    Thromb Res; 1992 Jun; 66(5):537-47. PubMed ID: 1523610
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of cyclic AMP in the inhibition of human platelet aggregation by quercetin, a flavonoid that potentiates the effect of prostacyclin.
    Beretz A; Stierle A; Anton R; Cazenave JP
    Biochem Pharmacol; 1982 Nov; 31(22):3597-600. PubMed ID: 6295405
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Competitive antagonism at thromboxane receptors in human platelets.
    Armstrong RA; Jones RL; Peesapati V; Will SG; Wilson NH
    Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sex differences in mouse platelet aggregation.
    Torres Duarte AP; Ramwell P; Myers A
    Thromb Res; 1986 Jul; 43(1):33-9. PubMed ID: 3088759
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thromboxane A2/prostaglandin H2 directly stimulates platelet shape change independent of secreted ADP.
    Parise LV; Venton DL; Le Breton GC
    J Pharmacol Exp Ther; 1982 Jul; 222(1):276-81. PubMed ID: 7086705
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Desensitisation in human and rabbit blood platelets.
    Hallam TJ; Ruggles PA; Scrutton MC; Wallis RB
    Thromb Haemost; 1982 Jun; 47(3):278-84. PubMed ID: 7112500
    [No Abstract]   [Full Text] [Related]  

  • 51. Fibrinogen binding is independent of an increase in intracellular calcium concentration in thrombin degranulated platelets.
    Pulcinelli FM; Daniel JL; Riondino S; Gazzaniga PP; Salganicoff L
    Thromb Haemost; 1995 Feb; 73(2):304-8. PubMed ID: 7792747
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evidence for platelet alphaIIb beta3 activation despite elevated cytosolic cAMP.
    Riondino S; Gazzaniga PP; Pulcinelli FM
    Thromb Haemost; 2001 Feb; 85(2):320-5. PubMed ID: 11246555
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aggregation of human and canine platelets: modulation by purine nucleotides.
    Soslau G; Arabe L; Parker J; Pelleg A
    Thromb Res; 1993 Oct; 72(2):127-37. PubMed ID: 8303650
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H; Stegmeier K
    Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Beclobrinic acid--a new hypolipidemic agent--inhibits in vitro human platelet activation by blocking prostaglandin synthesis.
    Anwer K; Gabis J; Romstedt K; Gojer C; Huzoor-Akbar
    Life Sci; 1985 Jul; 37(1):63-70. PubMed ID: 3925267
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Costimulation of the Gi-coupled ADP receptor and the Gq-coupled TXA2 receptor is required for ERK2 activation in collagen-induced platelet aggregation.
    Roger S; Pawlowski M; Habib A; Jandrot-Perrus M; Rosa JP; Bryckaert M
    FEBS Lett; 2004 Jan; 556(1-3):227-35. PubMed ID: 14706855
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of the stable endoperoxide analog U-46619 on prostacyclin production and cyclic AMP levels in bovine endothelial cells.
    Nicholson NS; Smith SL; Fuller GC
    Thromb Res; 1984 Jul; 35(2):183-92. PubMed ID: 6089372
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effects of alpha adrenergic agents on human platelet aggregation.
    Hsu CY; Knapp DR; Halushka PV
    J Pharmacol Exp Ther; 1979 Mar; 208(3):366-70. PubMed ID: 34707
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Augmentation of U46619 induced human platelet aggregation by aspirin.
    Kim JM; Koo YK; Jin J; Lee YY; Park S; Yun-Choi HS
    Platelets; 2009 Mar; 20(2):111-9. PubMed ID: 19235053
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Platelet dysfunction in Noonan's syndrome. A case with a platelet cyclooxygenase-like deficiency and chronic idiopathic thrombocytopenic purpura.
    Flick JT; Singh AK; Kizer J; Lazarchick J
    Am J Clin Pathol; 1991 May; 95(5):739-42. PubMed ID: 1902619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.